Elisa Sensi
- Oncology top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Pathology and Forensic Medicine top 2%
- Surgery top 10%
- Co-authors
- Cristiana LupiGabriella FontaniniAlfredo FalconeFotios LoupakisChiara CremoliniCarlotta AntoniottiSara LonardiCristina Granetto
- Topics
- Colorectal Cancer Treatments and Studies (16 papers)Lung Cancer Treatments and Mutations (11 papers)BRCA gene mutations in cancer (8 papers)
- Journals
- Journal of Clinical OncologyThe Journal of Clinical Endocrinology & MetabolismThe Lancet Oncology
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Elisa Sensi
43 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 1.5k
- Molecular Biology 609
- Pulmonary and Respiratory Medicine 586
- Pathology and Forensic Medicine 555
- Surgery 481
Countries citing papers authored by Elisa Sensi
This map shows the geographic impact of Elisa Sensi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Sensi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Sensi more than expected).
Fields of papers citing papers by Elisa Sensi
This network shows the impact of papers produced by Elisa Sensi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Sensi. The network helps show where Elisa Sensi may publish in the future.
Co-authorship network of co-authors of Elisa Sensi
This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Sensi. A scholar is included among the top collaborators of Elisa Sensi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Sensi. Elisa Sensi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 11 | |
| 3 | 2 | |
| 4 | 28 | |
| 5 | 13 | |
| 6 | 221 | |
| 7 | FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE studybreakdown → | 733 |
| 8 | 5 | |
| 9 | 60 | |
| 10 | 29 | |
| 11 | 76 | |
| 12 | 138 | |
| 13 | Folfoxiri plus Bevacizumab as first-line treatment of BRAF mutant metastatic colorectal cancer patients. | 4 |
| 14 | 190 | |
| 15 | 155 | |
| 16 | 23 | |
| 17 | 42 | |
| 18 | 15 | |
| 19 | 5 | |
| 20 | 91 |
About Elisa Sensi
Elisa Sensi is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 2.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Lung Cancer Treatments and Mutations (11 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Oncology (1.5k citations), Hepatology (423 citations) and Pathology and Forensic Medicine (555 citations). Elisa Sensi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Cristiana Lupi, Gabriella Fontanini, Alfredo Falcone, Fotios Loupakis, Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi, Cristina Granetto, Fulvio Basolo and Alberto Zaniboni. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.